Wordt geladen...
Bronchoesophageal fistula formation after three courses of nivolumab for carcinoma of unknown primary with a subgroup of lung squamous cell carcinoma
Immune checkpoint inhibitors (ICIs) are widely used in both monotherapy and combination chemotherapy for various types of cancers. Nivolumab is the most popular among ICIs, and the number of adapted malignant diseases for nivolumab is increasing. Bronchoesophageal fistula formation is a serious comp...
Bewaard in:
| Gepubliceerd in: | Oxf Med Case Reports |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7768526/ https://ncbi.nlm.nih.gov/pubmed/33391772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omaa116 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|